0 results available. Select is focused ,type to refine list, press Down to open the menu,
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibres...
The following section summarizes insights on Vyne Therapeutics Inc's Upside (Analyst Target):
We've identified the following companies as similar to Vyne Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Upside (Analyst Target) in the predictions category include:
The percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price.
Upside (Analyst Target) is the percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price. Downside (Analyst Target) is the inverse of this metric.
Upside = (Analyst Price Target / Stock Price) - 1
The chart above depicts the distribution of upside (analyst target) for companies operating in the Healthcare sector in the Developed economic region. Over 1,480 companies were considered in this analysis, and 1,424 had meaningful values. The average upside (analyst target) of companies in the sector is 297.5% with a standard deviation of 532.4%.
Vyne Therapeutics Inc's Upside (Analyst Target) of 281.9% ranks in the 71.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,484 |
| Included Constituents | 1,424 |
| Min | -3.9% |
| Max | 4,389.7% |
| Median | 107.2% |
| Mean | 297.5% |
| Standard Deviation | 532.4% |
You can find companies with similar upside (analyst target) using this stock screener.